Journal article

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor

Rebecca A Lew, Fiona J Warner, Iresha Hanchapola, Michael A Yarski, Jay Manohar, Louise M Burrell, A Ian Smith



Angiotensin-converting enzyme 2 (ACE2) is thought to act in an opposing manner to its homologue, angiotensin-converting enzyme (ACE), by inactivating the vasoconstrictor peptide angiotensin II and generating the vasodilatory fragment, angiotensin(1-7). Both ACE and ACE2 are membrane-bound ectoenzymes and may circulate in plasma as a consequence of a proteolytic shedding event. In this study, we show that ACE2 circulates in human plasma, but its activity is suppressed by the presence of an endogenous inhibitor. Partial purification of this inhibitor indicated that the inhibitor is small, hydrophilic and cationic, but not a divalent metal cation. These observations led us to develop a method f..

View full abstract

University of Melbourne Researchers